0001140361-13-037057.txt : 20130926 0001140361-13-037057.hdr.sgml : 20130926 20130926171351 ACCESSION NUMBER: 0001140361-13-037057 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20130926 DATE AS OF CHANGE: 20130926 EFFECTIVENESS DATE: 20130926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROVECTUS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000315545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900031917 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-203611 FILM NUMBER: 131117391 BUSINESS ADDRESS: STREET 1: 7327 OAK RIDGE HWY STREET 2: SUITE B CITY: KNOXVILLE STATE: TN ZIP: 37931 BUSINESS PHONE: 865-769-4011 MAIL ADDRESS: STREET 1: 7327 OAK RIDGE HWY STREET 2: SUITE B CITY: KNOXVILLE STATE: TN ZIP: 37931 FORMER COMPANY: FORMER CONFORMED NAME: ZAMAGE DIGITAL IMAGING INC DATE OF NAME CHANGE: 20011126 FORMER COMPANY: FORMER CONFORMED NAME: SPM GROUP INC DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0707 D LIVE 0000315545 PROVECTUS PHARMACEUTICALS INC 7327 OAK RIDGE HWY SUITE A KNOXVILLE TN TENNESSEE 37931 866-594-5999 NEVADA Zamage Digital Imaging Inc. SPM Group Inc. ZAMAGE DIGITAL IMAGING INC SPM GROUP INC Corporation true Peter R. Culpepper 7327 Oak Ridge Highway SUITE A Knoxville TN TENNESSEE 37931 Executive Officer CFO, COO, CAO Alfred E. Smith IV 7327 Oak Ridge Highway SUITE A Knoxville TN TENNESSEE 37931 Director Kelly M. McMasters 7327 Oak Ridge Highway SUITE A Knoxville TN TENNESSEE 37931 Director H. Craig Dees 7327 Oak Ridge Highway SUITE A Knoxville TN TENNESSEE 37931 Executive Officer Director CEO Timothy C. Scott 7327 Oak Ridge Highway SUITE A Knoxville TN TENNESSEE 37931 Executive Officer Director President Jan Koe 7327 Oak Ridge Highway SUITE A Knoxville TN TENNESSEE 37931 Director Eric A. Wachter 7327 Oak Ridge Highway SUITE A Knoxville TN TENNESSEE 37931 Executive Officer Chief Technology Officer Pharmaceuticals No Revenues 06b false 2013-03-12 false true true false 25000 Network 1 Financial Securities, Inc. 13577 None None The Galleria, Penthouse 2 Bridge Avenue, Building 2 Red Bank NJ NEW JERSEY 07701 CT CONNECTICUT FL FLORIDA IL ILLINOIS KY KENTUCKY MN MINNESOTA NJ NEW JERSEY NY NEW YORK OH OHIO PA PENNSYLVANIA TX TEXAS WI WISCONSIN VA VIRGINIA NC NORTH CAROLINA TN TENNESSEE true Maxim Group LLC 1207087 None None 405 Lexington Avenue New York NY NEW YORK 10174 AK ALASKA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA HI HAWAII IL ILLINOIS IN INDIANA LA LOUISIANA MA MASSACHUSETTS MD MARYLAND MI MICHIGAN MO MISSOURI NC NORTH CAROLINA NJ NEW JERSEY NY NEW YORK OH OHIO OK OKLAHOMA PR PUERTO RICO SC SOUTH CAROLINA TN TENNESSEE TX TEXAS VA VIRGINIA VT VERMONT WA WASHINGTON WI WISCONSIN PA PENNSYLVANIA false 16000000 7798037 8201963 false 67 1600000 true 0 Placement agent will receive a 10% commission plus warrants to purchase 10% of the aggregate number of shares of common stock issued in the offering, with an exercise price of $1.00 per share. 1000000 true false PROVECTUS PHARMACEUTICALS INC /s/Peter R. Culpepper Peter R. Culpepper Chief Financial Officer 2013-09-26